Apton Biosystems is developing a high throughput system that can sequence the human genome for $10. The system can also analyze thousands of proteins and nucleic acids with superior sensitivity and accuracy. The platform will enable biomarker discovery, early disease detection and therapeutic monitoring, advancing preventive health and precision medicine.